Ever since health officials announced Canada's first known case of rare, post-vaccination blood clots back in April, scientists have been racing to learn more about what causes the potentially deadly condition — and how to treat it. The potential effectiveness was outlined in three case studies featuring some of the first Canadian patients who developed post-vaccine blood clots, which was published Wednesday in The New England Journal of Medicine. WATCH | Researcher explains IVIG treatment:McMaster researcher explains how IVIG treatment works for post-vaccine blood clots CBC News 0:43 Ishac Nazy is one of the researchers behind a new paper focused on treatments for post-vaccine blood clots, and the scientific director of the McMaster Platelet Immunology Laboratory. So how — and why — does IVIG seem to work for patients with post-vaccine blood clots? IVIG treatment seems to work by flooding the system with different antibodies, which "outcompete" the patient's own supply to prevent the chain of events leading to blood clots, Nazy explained.

Source: CBC News June 09, 2021 21:00 UTC